How Has the Vascular Stent Market Size Evolved in Recent Years?
The vascular stent market has seen considerable growth due to a variety of factors.
• The size of the vascular stent market has seen substantial growth over the past few years. The market which was valued at $15.85 billion in 2024, is projected to increase to $17.36 billion in 2025, with a compound annual growth rate (CAGR) of 9.5%. This progress observed in the historical period can be credited to factors such as clinical research and development, drug-eluting stents (des), the emergence of balloon angioplasty, nascent stent innovations, and the enhancement of physician training and skills.
What are the Market Size and Expected Growth Rates for the Vascular Stent Market By 2029?
The Vascular Stent market is expected to maintain its strong growth trajectory in upcoming years.
• The market size of vascular stents is anticipated to experience significant expansion in the coming years, reaching $25.76 billion by 2029, with a compound annual growth rate of 10.4%.
This predicted growth for the forecast period can be attributed to various factors, such as an emphasis on preventative cardiovascular health care, a shift to outpatient procedures, cost-effectiveness and value-based health care, bioabsorbable stents and next-generation materials, and expansion of endovascular interventions. The forthcoming period is expected to witness major trends such as advancements in stent coatings and materials, heightened patient education and awareness, a move towards outpatient settings, and a focus on cost-effectiveness.
Which Key Drivers Are Propelling The Vascular Stent Market's Growth?
The vascular stent market is expected to expand due to the growing prevalence of vascular diseases. These diseases, which are part of the cardiovascular diseases (CVD) group, ordinarily impact the blood vessels, both arteries and veins. Vascular stents play a crucial role in treating a variety of these diseases by ensuring a steady supply of oxygen-rich blood to the heart. The Center for Disease Control and Prevention, a US-based federal public health agency, revealed in May 2023 that approximately 702,880 individuals succumbed to heart disease in the United States in 2022, accounting for 1 in every 5 deaths. Consequently, an upturn in cardiovascular diseases (CVDs) is anticipated to fuel the advancement of the vascular stent market.
What Are The Key Segments Within The Global Vascular Stent Market?
The vascular stent market covered in this report is segmented –
1) By Product: Coronary Stents, Peripheral Vascular Stents, Ever Stent Grafts
2) By Type: Bare Metal Stent, Bio-Engineered Stent, Bioresorbable Vascular Scaffold, Drug Eluting Stent, Dual Therapy Stent
3) By Material: Metallic Stents, Cobalt-Chromium, Platinum Chromium, Nickel Titanium, Stainless Steel, Polymers Stents
4) By Mode Of Delivery: Balloon-Expandable Stent, Self-Expanding Stent
5) By End-User: Ambulatory Surgical Center, Cardiac Center, Hospital
Subsegments:
1) By Coronary Stents: Drug-Eluting Coronary Stents, Bare Metal Coronary Stents
2) By Peripheral Vascular Stents: Drug-Eluting Peripheral Stents, Bare Metal Peripheral Stents
3) By EVAR Stent Grafts (Endovascular Aneurysm Repair): Aortoiliac Stent Grafts, Fenestrated Stent Grafts, Branch Stent Grafts
Pre-Book The Vascular Stent Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
How Are New Trends Impacting The Size Of The Vascular Stent Market?
The rise in technological progress is an emerging trend in the vascular stent market. Numerous firms are investing in bio-sensing technology, state-of-the-art integrated stents, and drug-eluting coronary stent systems to establish a competitive advantage. For example, in 2022, Indian medical equipment manufacturer Translumina, introduced VIVO ISAR, a cutting-edge dual drug polymer-free coated stent (DDCS). This new generation stent uniquely combines a stent with an excellent safety portfolio without sacrificing drug release kinetics. It employs Probucol, an antioxidant and lipid-lowering drug, as the transporter for Sirolimus release (an anti-restenosis drug), hence creating a polymer-free DES platform with uncompromised safety and efficacy.
Who Are the Key Players In The Vascular Stent Market?
Major companies operating in the vascular stent market include:
• Medtronic PLC
• Abbott Laboratories
• Boston Scientific Corporation
• Biotronik SE & Co. KG
• B. Braun Melsungen AG
• Terumo Corporation
• Meril Life Sciences Pvt. Ltd.
• JOTEC GmbH
• W. L. Gore & Associates Inc.
• MicroPort Scientific Corporation
• Translumina GmbH
• Lepu Medical Technology Co. Ltd.
• Purple Medical Solution Pvt. Ltd.
• Sahajanand Medical Technologies Pvt. Ltd.
• Stentys SA
• Osypka AG
• Cook Medical Inc.
• Cordis Corporation
• Endologix Inc.
• Johnson & Johnson Inc.
• EP Medsystems Inc.
What Are The Regional Insights Into The Vascular Stent Market?
North America was the largest region in the vascular stent market share in 2024. The regions covered in the vascular stent market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
